Stocks and Investing Stocks and Investing
Thu, September 1, 2016
Wed, August 31, 2016
Tue, August 30, 2016
Mon, August 29, 2016

Josh Schimmer Initiated (TBPH) at Strong Buy and Held Target at $41 on, Aug 29th, 2016


Published on 2024-10-25 18:19:17 - WOPRAI, Josh Schimmer
  Print publication without navigation


Josh Schimmer of Evercore ISI Group, Initiated "Theravance Biopharma, Inc." (TBPH) at Strong Buy and Held Target at $41 on, Aug 29th, 2016.

Josh, nor any peers, have made any analyst calls on TBPH in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources